157 related articles for article (PubMed ID: 22995312)
1. Identification of structural traits that increase the antimicrobial activity of a chimeric peptide of human β-defensins 2 and 3.
Spudy B; Sönnichsen FD; Waetzig GH; Grötzinger J; Jung S
Biochem Biophys Res Commun; 2012 Oct; 427(1):207-11. PubMed ID: 22995312
[TBL] [Abstract][Full Text] [Related]
2. Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules.
Jung S; Mysliwy J; Spudy B; Lorenzen I; Reiss K; Gelhaus C; Podschun R; Leippe M; Grötzinger J
Antimicrob Agents Chemother; 2011 Mar; 55(3):954-60. PubMed ID: 21189349
[TBL] [Abstract][Full Text] [Related]
3. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus.
Schibli DJ; Hunter HN; Aseyev V; Starner TD; Wiencek JM; McCray PB; Tack BF; Vogel HJ
J Biol Chem; 2002 Mar; 277(10):8279-89. PubMed ID: 11741980
[TBL] [Abstract][Full Text] [Related]
4. Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis.
Corrales-Garcia L; Ortiz E; Castañeda-Delgado J; Rivas-Santiago B; Corzo G
Protein Expr Purif; 2013 May; 89(1):33-43. PubMed ID: 23459290
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes.
Midorikawa K; Ouhara K; Komatsuzawa H; Kawai T; Yamada S; Fujiwara T; Yamazaki K; Sayama K; Taubman MA; Kurihara H; Hashimoto K; Sugai M
Infect Immun; 2003 Jul; 71(7):3730-9. PubMed ID: 12819054
[TBL] [Abstract][Full Text] [Related]
6. Efficient production of human beta-defensin 2 (HBD2) in Escherichia coli.
Vargues T; Morrison GJ; Seo ES; Clarke DJ; Fielder HL; Bennani J; Pathania U; Kilanowski F; Dorin JR; Govan JR; Mackay CL; Uhrín D; Campopiano DJ
Protein Pept Lett; 2009; 16(6):668-76. PubMed ID: 19519528
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activities of synthetic peptides corresponding to the carboxy-terminal region of human beta-defensins 1-3.
Krishnakumari V; Singh S; Nagaraj R
Peptides; 2006 Nov; 27(11):2607-13. PubMed ID: 16860904
[TBL] [Abstract][Full Text] [Related]
8. Host defense peptide-derived privileged scaffolds for anti-infective drug discovery.
Nigro E; Colavita I; Sarnataro D; Scudiero O; Daniele A; Salvatore F; Pessi A
J Pept Sci; 2017 Apr; 23(4):303-310. PubMed ID: 28078813
[TBL] [Abstract][Full Text] [Related]
9. Chimeric analogs of human β-defensin 1 and θ-defensin disrupt pre-established bacterial biofilms.
Mathew B; Olli S; Guru A; Nagaraj R
Bioorg Med Chem Lett; 2017 Aug; 27(15):3264-3266. PubMed ID: 28642103
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analysis of Avian β-defensin-6 and β-defensin-12: role of charge and disulfide bridges.
Yang M; Zhang C; Zhang X; Zhang MZ; Rottinghaus GE; Zhang S
BMC Microbiol; 2016 Sep; 16(1):210. PubMed ID: 27613063
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity and structure of a consensus human β-defensin and its comparison to a novel putative hBD10.
Rodriguez A; Pedersen MØ; Villegas E; Rivas-Santiago B; Villegas-Moreno J; Amero C; Norton RS; Corzo G
Proteins; 2020 Jan; 88(1):175-186. PubMed ID: 31325337
[TBL] [Abstract][Full Text] [Related]
12. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.
Wu Z; Hoover DM; Yang D; Boulègue C; Santamaria F; Oppenheim JJ; Lubkowski J; Lu W
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8880-5. PubMed ID: 12840147
[TBL] [Abstract][Full Text] [Related]
13. Human β-defensin 4 with non-native disulfide bridges exhibit antimicrobial activity.
Sharma H; Nagaraj R
PLoS One; 2015; 10(3):e0119525. PubMed ID: 25785690
[TBL] [Abstract][Full Text] [Related]
14. The Antibacterial Effects of an Antimicrobial Peptide Human β-Defensin 3 Fused with Carbohydrate-Binding Domain on Pseudomonas aeruginosa PA14.
Lin P; Li Y; Dong K; Li Q
Curr Microbiol; 2015 Aug; 71(2):170-6. PubMed ID: 25862466
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial characterization of site-directed mutagenesis of porcine beta defensin 2.
Huang XX; Gao CY; Zhao QJ; Li CL
PLoS One; 2015; 10(2):e0118170. PubMed ID: 25719446
[TBL] [Abstract][Full Text] [Related]
16. Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-β-defensin 3 and affect peptide's antibacterial activity in vitro.
Maisetta G; Brancatisano FL; Esin S; Campa M; Batoni G
Peptides; 2011 May; 32(5):1073-7. PubMed ID: 21335044
[TBL] [Abstract][Full Text] [Related]
17. The structural parameters for antimicrobial activity, human epithelial cell cytotoxicity and killing mechanism of synthetic monomer and dimer analogues derived from hBD3 C-terminal region.
Zhou L; Liu SP; Chen LY; Li J; Ong LB; Guo L; Wohland T; Tang CC; Lakshminarayanan R; Mavinahalli J; Verma C; Beuerman RW
Amino Acids; 2011 Jan; 40(1):123-33. PubMed ID: 20397033
[TBL] [Abstract][Full Text] [Related]
18. Structure and antimicrobial activity of platypus 'intermediate' defensin-like peptide.
Torres AM; Bansal P; Koh JM; Pagès G; Wu MJ; Kuchel PW
FEBS Lett; 2014 May; 588(9):1821-6. PubMed ID: 24694388
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of a soluble functional antimicrobial peptide, human beta-defensin 2, in Escherichia coli.
Xu Z; Peng L; Zhong Z; Fang X; Cen P
Biotechnol Prog; 2006; 22(2):382-6. PubMed ID: 16599550
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial characterization of human beta-defensin 3 derivatives.
Hoover DM; Wu Z; Tucker K; Lu W; Lubkowski J
Antimicrob Agents Chemother; 2003 Sep; 47(9):2804-9. PubMed ID: 12936977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
